Sign in
4

Changes in Ownership

ENANTA PHARMACEUTICALS INC Filed Acc 0001177648-20-000006

President and CEO gave up 3,122 shares (to pay taxes)

  • President and CEO acquired 10,395 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Luly Jay R. · President and CEO

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2020-02-12 Grant or award : show line 1 in the form +1,485 643,901 D
2020-02-12 Grant or award : show line 2 in the form +8,910 652,811 D
2020-02-12 Shares withheld for taxes : show line 3 in the form −3,122 $52.76 $164,717 649,689 D
Loading xslF345X03/edgar.xml…